Topics
July/August 2016 | What's New On The Anti-pdgf Front?
An Oral Drug for Treatment of AMD?
The potential for this proposed treatment option could be significant for many patients and their caregivers.
Carl C. Awh, MD
October 30, 2026
Octant Receives FDA Orphan Drug Designation for OCT-980 for the Treatment of Retinitis Pigmentosa
VisioSurgical Solutions Begins Development of Compact Surgical Robot for Retinal Surgery
October 29, 2026
Oculis to Present Privosegtor Data at Upcoming Ophthalmology and Neurology Conferences
Kiora Plans Multinational Phase 3 CRAO and Phase 2b NAION Trials of KIO-401
October 2026 Insert
Editorially Independent Content, Supported With Advertising From Asetllas
Editorially independent supported by Abbvie and Regenxbio
Free Print Subscription
Email Newsletter
Conference Calendar
